Univariate and multivariate Cox regression of the survival data was also performed; the statistics results showed that both GATAD1 gene amplification and GATAD1 hyper‐expression were independent predictors of poorer survival of glioma patients (Tables S5‐S8). The gene discussed is GATAD1; the disease is central nervous system cancer.